hesperadin,
hesperadin,
422513-13-1,
hesperadine,
UNII-PTR491OS14,
CHEBI:70726,
TCMDC-135395,
CHEMBL514409,
PTR491OS14,
AK174795,
N-[2,3-Dihydro-2-oxo-3-[(3Z)-phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-1H-indol-5-yl]ethanesulfonamide,
C29H32N4O3S,
(Z)-N-(2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indolin-5-yl)ethanesulfonamide,
(Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide,
N-[(3Z)-2-oxo-3-(phenyl{[4-(piperidin-1-ylmethyl)phenyl]amino}methylidene)-2,3-dihydro-1H-indol-5-yl]ethanesulfonamide,
N-{(3Z)-2-oxo-3-[phenyl({4-[(piperidin-1-yl)methyl]phenyl}amino)methylidene]-2,3-dihydro-1H-indol-5-yl}ethanesulfonamide,
Hesperadin/,
FE7,
MLS006011039,
GTPL8354,
SCHEMBL1116351,
SCHEMBL1116356,
KS-00001CVY,
DTXSID00195086,
QCR-213,
BDBM192753,
HMS3654N20,
BCP02222,
EX-A2067,
ZINC3944221,
ABP000303,
MFCD18074526,
s1529,
AKOS025404841,
AKOS030243077,
ZINC115270495,
CS-0213,
RL03628,
SB19304,
NCGC00346542-01,
AS-35163,
BC660019,
Ethanesulfonamide, N-(2,3-dihydro-2-oxo-3-((3Z)-phenyl((4-(1-piperidinylmethyl)phenyl)amino)methylene)-1H-indol-5-yl)-,
HY-12054,
SMR004702832,
AB0007890,
FT-0771055,
SW219406-1,
X7388,
S-7746,
J-523310,
N-[(3Z)-2-oxo-3-[phenyl({[4-(piperidin-1-ylmethyl)phenyl]amino})methylidene]-1H-indol-5-yl]ethanesulfonamide,
N-[(3Z)-2-oxo-3-[phenyl-[[4-(piperidin-1-ylmethyl)phenyl]amino]methylidene]-1H-indol-5-yl]ethanesulfonamide,
N-[(3Z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1H-indol-5-yl]ethanesulfonamide,
D05WSM,
cc-473,
CID10142586,
CID 10142586,
A4118,
A10448,
H1N,
N-[2-OXO-3-((E)-PHENYL{[4-(PIPERIDIN-1-YLMETHYL)PHENYL]IMINO}METHYL)-2,6-DIHYDRO-1H-INDOL-5-YL]ETHANESULFONAMIDE,